EarSwitch, founded in 2019, is at the forefront of transforming healthcare through its innovative in-ear biometric switch and sensor technology. Based in the United Kingdom, the company operates within the Health Care and Manufacturing sectors.
With the slogan, "Transforming how we monitor and diagnose health through in-ear innovation," EarSwitch is dedicated to improving health diagnostics and patient connectivity. Their proprietary EarMetrics sensor technology is designed to enhance early diagnosis, support diverse patient demographics, and ultimately improve clinical outcomes. The approach of incorporating equality, diversity, and inclusivity into their offerings highlights their commitment to a holistic healthcare strategy.
The company's innovative trajectory has garnered the attention of investors, evidenced by a recent £1.20M Seed Round investment, led by Praetura Ventures as of 01 March 2024. This support indicates strong confidence in EarSwitch's potential to revolutionize healthcare monitoring and diagnostics.